Investors in Ev

NetScientific PLC (AIM: NSCI), we are a deep tech and life sciences venture capital investment group with a diverse international portfolio of innovative companies. Based in London, United Kingdom, our focus is on identifying, investing in, and nurturing high-growth businesses both locally and globally. Our approach involves adding significant value through proactive portfolio management, guiding companies towards key value inflection points, and achieving investment returns through strategic liquidity events. We distinguish ourselves by adopting a capital-light strategy, strategically managing our balance sheet, and syndicating investments through our wholly owned VC subsidiary, EMV Capital. This lean structure allows us to effectively support a broad portfolio while maintaining flexibility and scalability. Listed on AIM, a market operated by the London Stock Exchange, we uphold our commitment to transparency and accountability in all our investment operations.

VP Capital is a global investment vehicle specializing in the technology sector. As an investment firm, VP Capital focuses on identifying and supporting innovative technology companies worldwide. They provide strategic capital and operational support to help these companies accelerate their growth and achieve market leadership. VP Capital leverages its global network and industry expertise to identify promising investment opportunities and empower entrepreneurs to drive innovation and success in the technology sector. Their commitment lies in fostering the development of transformative technologies and contributing to the advancement of the global tech ecosystem.

Northzone, we are a technology investment partnership with over two decades of experience. We have earned the trust of some of the best entrepreneurs who choose us as their long-term growth partner. With offices across the Nordics, London, and New York, we work tirelessly to connect our portfolio companies with customers, business partners, and top talent on a global scale. As former entrepreneurs ourselves, we have experienced the challenges and opportunities from both sides of the table. Our approach is rooted in building strong relationships with our founders, placing their success and vision at the core of our business strategy.

Kerdos Ventures, we specialize in investing in early-stage and growth-stage companies with significant growth potential. Our focus sectors include technology, healthcare, consumer goods, and other innovative industries. We aim to provide more than just capital; we offer strategic support and industry expertise to help our portfolio companies thrive and achieve their full potential.

Mérieux Equity Partners is one of the most recognized and active European Investment firms in the Healthcare sector. We support the development and growth of high-potential companies from business launch to large scale deployment through capital investment and tailor-made support based on our strong sector expertise and international network. We are an agile investor with a flexible approach in terms of minority or majority stakes. Our main focus is partnering with and investing alongside management teams.

Founded in 2008 by and for founders, Newfund Capital is an early-stage VC firm actively investing in France and the USA. We foster a strong entrepreneurial culture and support the ambitions of our portfolio companies through various initiatives. With $300 million in assets under management (AUM), primarily subscribed by entrepreneurs and family offices, Newfund focuses on a people-driven investment strategy. We prioritize entrepreneurs who are deeply committed to realizing their vision, valuing their individuality and strengths. Our initial investments range from $250k to $2M, with smaller commitments starting at $100k in the Nouvelle Aquitaine region through our NAEH fund. Beyond financial support, we offer access to our operating team and a robust cross-border ecosystem to help founders achieve product-market fit and accelerate growth. At Newfund, we emphasize founders with significant skin in the game, reflecting our own commitment as a major limited partner (LP) in each fund. Our interests are fully aligned with those of our portfolio companies, ensuring a partnership without conflicts of interest.

Integra Holdings is a unique venture fund that combines academic excellence, funding and R&D guidance together with a strong and proven business network — the most important elements necessary to bring academic innovation to the market. Focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in their respective fields, Integra takes a hands-on approach by providing our portfolio companies the strategic planning and business development necessary to bring their technology to the market. Founded by Yissum, the Hebrew University's technology transfer company, Integra capitalizes on the innovative applied research constantly flowing from the renowned Hebrew University of Jerusalem, Israel.

Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio. A dozen investment professionals identify the most promising digital, tangible, and health & bio startups. Verve Ventures provides its pan-European network of selected private and institutional investors access to those top-tier investment opportunities.

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds. Finding and fueling tomorrow's advances in precision medicine.

Mountain Partners is a global multi-fund manager. It acts as a global holding company for a diversified investment portfolio and a global network of VC funds that spans three continents. Founded in 2005, the Mountain Partners House of Funds today encompasses 16 independent VC funds & investment vehicles. In total, we are invested in more than 170 active portfolio companies. A pioneer of investing in GP stakes in VC funds, we partner with the most promising managers in high-growth markets.

We are Capagro, the first European independent Venture Capital fund dedicated to impactful and innovative AgTech & FoodTech startups. We invest across the entire value chain, from farm to fork, to accelerate the development of these companies and help them change the world for the better. Our fund currently manages approximately €200 million and is backed by leading international agribusinesses and institutional LPs: we leverage our network to benefit our portfolio companies and the international AgriFoodTech ecosystem.

Serpentine Ventures (SERV) is the investment arm of the Swiss Ventures Group. SERV was founded by experienced entrepreneurs and financial services professionals and works with exceptional entrepreneurial talent to build and invest in technology driven businesses. A leading Swiss advisor for venture assets.